Aspirin Use Tied to Longer Bladder, Breast Cancer Survival
However, aspirin use in older adults not tied to incidence of various cancer types (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 27, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Urology, Journal, Source Type: news

Post-Miscarriage, Aspirin May Affect Next Pregnancy
Could something as simple as taking a low-dose aspirin once a day guard against pregnancy loss among women who have already suffered miscarriages? (Source: WebMD Health)
Source: WebMD Health - January 26, 2021 Category: Consumer Health News Source Type: news

For Women Who've Miscarried, Aspirin Before, During Pregnancy Could Improve Outcomes
TUESDAY, Jan. 26, 2021 -- Could something as simple as taking a low-dose aspirin once a day guard against pregnancy loss among women who have already suffered miscarriages? New research suggests that's the case, though exactly how low-dose aspirin... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 26, 2021 Category: General Medicine Source Type: news

Adherence to Low-Dose Aspirin Improves Pregnancy Outcomes
TUESDAY, Jan. 26, 2021 -- Adherence to a low-dose aspirin (LDA) regimen improves pregnancy outcomes for women with previous pregnancy loss, according to a study published online Jan. 26 in the Annals of Internal Medicine. Ashley I. Naimi, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2021 Category: Pharmaceuticals Source Type: news

Can Daily Aspirin Lower Colon Cancer Risk?
Title: Can Daily Aspirin Lower Colon Cancer Risk?Category: Health NewsCreated: 1/25/2021 12:00:00 AMLast Editorial Review: 1/26/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 26, 2021 Category: Cancer & Oncology Source Type: news

Daily Aspirin Can Lower Colon Cancer Risk, But Age Matters
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 25, 2021 Category: Cancer & Oncology Tags: Family Medicine, Oncology, News, Source Type: news

Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages
NIH study examines pattern of aspirin use, rather than difference between aspirin and placebo groups. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 25, 2021 Category: American Health Source Type: news

Daily Aspirin Can Lower Colon Cancer Risk, But Age Matters
MONDAY, Jan. 25, 2021 -- Low-dose aspirin may help some people curb their risk of developing colon cancer -- but not if they wait until age 70 to start, a large, new study suggests. Researchers found that when people began using aspirin in their 50s... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 25, 2021 Category: General Medicine Source Type: news

Aspirin Use Cuts CRC Risk in Those Initiating Use Before Age 70
THURSDAY, Jan. 21, 2021 -- Regular use of aspirin is associated with a reduced risk for colorectal cancer (CRC) among those with initiation of aspirin before age 70 years, according to a study published online Jan. 21 in JAMA Oncology. Chuan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2021 Category: Pharmaceuticals Source Type: news

Does aspirin lower colorectal cancer risk in older adults? It depends on when they start
(Massachusetts General Hospital) A new study has found that there is no protection against colorectal cancer if people begin taking aspirin regularly after age 70. However, there appears to be such protection if aspirin is started before age 70 and continued. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 21, 2021 Category: Cancer & Oncology Source Type: news

Regular aspirin use can lower risk for death in bladder, breast cancers, study finds
People who take aspirin at least three times per week are more likely to survive bladder cancer, according to an analysis published Friday by JAMA Network Open. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 15, 2021 Category: Consumer Health News Source Type: news

FDA Drug Safety Communication: FDA warns about serious bleeding risk with over-the-counter antacid products containing aspirin
[06-06-2016] The U.S. Food and Drug Administration (FDA) is warning consumers about the risk of serious bleeding when using nonprescription, also known as over-the-counter or OTC, aspirin-containing antacid products to treat heartburn, sour stomach, acid indigestion, or upset stomach. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 7, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Brick (NJ) EMTs Save Man Who Suffered Widowmaker Heart Attack
Amanda Oglesby Asbury Park Press (MCT) BRICK – Joe Holler was mowing his lawn before noon on Halloween when he began to feel weak. Worried that he was having a heart attack, Holler took a baby aspirin and called 911. Holler’s quick thinking and a 6-minute response from Brick EMTs Joseph Sharkey and Brian Schwarz averted what would otherwise have been a tragedy, police said in a news release. Within minutes of their arrival, and that of Patrolman Daniel Fogarty, Holler’s pain worsened. Before the ambulance pulled away from his home, Holler slipped into unco...
Source: JEMS Patient Care - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Cardiac & Resuscitation News News Feed Patient Care Cardiac Arrest EMT New Jersey Source Type: news

Brick (NJ) EMTs Save Man Who Suffered Widowmaker Heart Attack
Amanda Oglesby Asbury Park Press (MCT) BRICK – Joe Holler was mowing his lawn before noon on Halloween when he began to feel weak. Worried that he was having a heart attack, Holler took a baby aspirin and called 911. Holler’s quick thinking and a 6-minute response from Brick EMTs Joseph Sharkey and Brian Schwarz averted what would otherwise have been a tragedy, police said in a news release. Within minutes of their arrival, and that of Patrolman Daniel Fogarty, Holler’s pain worsened. Before the ambulance pulled away from his home, Holler slipped into unco...
Source: JEMS Administration and Leadership - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Cardiac & Resuscitation News News Feed Patient Care Cardiac Arrest EMT New Jersey Source Type: news

Brick (NJ) EMTs Save Man Who Suffered Widowmaker Heart Attack
Amanda Oglesby Asbury Park Press (MCT) BRICK – Joe Holler was mowing his lawn before noon on Halloween when he began to feel weak. Worried that he was having a heart attack, Holler took a baby aspirin and called 911. Holler’s quick thinking and a 6-minute response from Brick EMTs Joseph Sharkey and Brian Schwarz averted what would otherwise have been a tragedy, police said in a news release. Within minutes of their arrival, and that of Patrolman Daniel Fogarty, Holler’s pain worsened. Before the ambulance pulled away from his home, Holler slipped into unco...
Source: JEMS Latest News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Cardiac & Resuscitation News News Feed Patient Care Cardiac Arrest EMT New Jersey Source Type: news

Brick (NJ) EMTs Save Man Who Suffered Widowmaker Heart Attack
Amanda Oglesby Asbury Park Press (MCT) BRICK – Joe Holler was mowing his lawn before noon on Halloween when he began to feel weak. Worried that he was having a heart attack, Holler took a baby aspirin and called 911. Holler’s quick thinking and a 6-minute response from Brick EMTs Joseph Sharkey and Brian Schwarz averted what would otherwise have been a tragedy, police said in a news release. Within minutes of their arrival, and that of Patrolman Daniel Fogarty, Holler’s pain worsened. Before the ambulance pulled away from his home, Holler slipped into unco...
Source: JEMS: Journal of Emergency Medical Services News - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Cardiac & Resuscitation News News Feed Patient Care Cardiac Arrest EMT New Jersey Source Type: news

Brick (NJ) EMTs Save Man Who Suffered Widowmaker Heart Attack
Amanda Oglesby Asbury Park Press (MCT) BRICK – Joe Holler was mowing his lawn before noon on Halloween when he began to feel weak. Worried that he was having a heart attack, Holler took a baby aspirin and called 911. Holler’s quick thinking and a 6-minute response from Brick EMTs Joseph Sharkey and Brian Schwarz averted what would otherwise have been a tragedy, police said in a news release. Within minutes of their arrival, and that of Patrolman Daniel Fogarty, Holler’s pain worsened. Before the ambulance pulled away from his home, Holler slipped into unco...
Source: JEMS Operations - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Cardiac & Resuscitation News News Feed Patient Care Cardiac Arrest EMT New Jersey Source Type: news

Brick (NJ) EMTs Save Man Who Suffered Widowmaker Heart Attack
Amanda Oglesby Asbury Park Press (MCT) BRICK – Joe Holler was mowing his lawn before noon on Halloween when he began to feel weak. Worried that he was having a heart attack, Holler took a baby aspirin and called 911. Holler’s quick thinking and a 6-minute response from Brick EMTs Joseph Sharkey and Brian Schwarz averted what would otherwise have been a tragedy, police said in a news release. Within minutes of their arrival, and that of Patrolman Daniel Fogarty, Holler’s pain worsened. Before the ambulance pulled away from his home, Holler slipped into unco...
Source: JEMS Special Topics - December 16, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Cardiac & Resuscitation News News Feed Patient Care Cardiac Arrest EMT New Jersey Source Type: news

Lifelong Aspirin for All in the Secondary Prevention of CCS? Lifelong Aspirin for All in the Secondary Prevention of CCS?
Emerging evidence suggests that reappraisal may be warranted regarding the efficacy of lifelong aspirin in some patients with chronic coronary syndrome.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Plants on aspirin
(Institute of Science and Technology Austria) For centuries humans were using willow barks to treat a headache or an inflamed tooth. Later, the active ingredient, the plant hormone salicylic acid, was used to develop painkillers like Aspirin. But what happens, if plants are treated with these painkillers? By doing so, Scientists at the Institute of Science and Technology (IST) Austria discovered an unexpected bioactivity of human pharmaceuticals in plants. The scientists published their study in the journal Cell Reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2020 Category: International Medicine & Public Health Source Type: news

Norgesic (Orphenadrine Citrate with Aspirin and Caffeine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 30, 2020 Category: Drugs & Pharmacology Source Type: news

Rivaroxaban to Prevent Brain Infarcts and Cognitive Decline Rivaroxaban to Prevent Brain Infarcts and Cognitive Decline
Might rivaroxaban with or without aspirin significantly reduce the rate of covert infarct over aspirin alone among patients with stable coronary and peripheral vascular disease?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 25, 2020 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Potential New Option: 1-Month DAPT Post DES, Then Aspirin Alone Potential New Option: 1-Month DAPT Post DES, Then Aspirin Alone
One month of dual-antiplatelet therapy followed by aspirin monotherapy in patients who've received a drug-eluting stent proved noninferior to 6-12 months of DAPT in a large trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 24, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

What is a laceration?
It's human nature to avoid contact with sharp objects because we know they can cause us an ordeal of pain, bleeding and scars. However, when accidents happen, you may be left caring for a laceration wound. Here's your quick guide to laceration treatment and prevention: Lacerations are open wounds caused by sharp objects. What are lacerations? This type of open wound occurs when a sharp object cuts or tears the skin. According to Healthline, laceration wounds are often the result of accidents with knives, tools or machinery. Extensive bleeding is possible, especially with deep lacerations. How do you treat a lacer...
Source: Advanced Tissue - November 23, 2020 Category: Dermatology Authors: AdvancedTissue Tags: Wound Care Source Type: news

Aspirin and Statins in Chronic Hepatitis B: It's Complicated Aspirin and Statins in Chronic Hepatitis B: It's Complicated
Statins play a bigger part than aspirin in reducing risk for hepatocellular carcinoma in patients with hepatitis B, new research shows, and cirrhosis seems to cancel any beneficial effect of aspirin.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 19, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

AHA: Polypill, With or Without Aspirin, Reduces Cardiovascular Events
WEDNESDAY, Nov. 18, 2020 -- A polypill comprising statins and blood pressure-lowering drugs, with or without aspirin, is associated with a lower incidence of cardiovascular events, according to a study published online Nov. 13 in the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2020 Category: Pharmaceuticals Source Type: news

Target Ticagrelor to Minor Stroke, TIA Patients With AS Target Ticagrelor to Minor Stroke, TIA Patients With AS
Latest results from the THALES trial show that dual antiplatelet therapy with ticagrelor and aspirin has the best risk-benefit ratio for patients who also have ipsilateral arterial stenosis.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 17, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Newer blood thinner plus aspirin reduced stroke risk by 27% in patients with heart plaque
(American Heart Association) Patients who suffered a 'warning stroke' were less likely to have another stroke or die within 30 days if treated with a combination of aspirin and a newer blood thinner, ticagrelor. Researchers say that for patients with minor stroke treated within 24 hours of symptom onset, clinicians should consider the combination of ticagrelor plus aspirin to prevent a subsequent stroke. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 17, 2020 Category: International Medicine & Public Health Source Type: news

'Polypill' reduces risk for heart attack, stroke by up to 40%, study finds
A so-called " polypill " that combines three blood pressure medications and a cholesterol-lowering drug, when taken with aspirin, reduces risk for heart attack or stroke by up to 40%, according to a study published Friday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 13, 2020 Category: Consumer Health News Source Type: news

Big study supports cheap combo pill to lower heart risks
Researchers say a cheap, daily pill combining four cholesterol and blood pressure medicines taken with low-dose aspirin can cut the risk of heart attacks, strokes and heart-related deaths by nearly one third (Source: ABC News: Health)
Source: ABC News: Health - November 13, 2020 Category: Consumer Health News Tags: Health Source Type: news

Disabling Stroke Reduced With Ticagrelor After Minor Stroke, TIA Disabling Stroke Reduced With Ticagrelor After Minor Stroke, TIA
A new exploratory analysis from the THALES trial shows a reduction in disabling stroke with ticagrelor plus aspirin versus aspirin alone.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 11, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need f...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Aspirin to be tested in UK as potential coronavirus treatment
Recovery trial researchers look at whether drug can reduce risk of dangerous blood clotsCoronavirus – latest updatesSee all our coronavirus coverageThousands of coronavirus patients in Britain will be given aspirin as part of a trial to determine whether the painkiller can reduce the risk of dangerous blood clots.The cheap and widely available drug has been added to a list of potential treatments to be tested as part of theRandomised Evaluation of Covid-19 therapy (Recovery) trial, one of the biggest in Britain.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 7, 2020 Category: Science Authors: Aaron Walawalkar Tags: Coronavirus Aspirin UK news Science Source Type: news

FDA Broadens Ticagrelor Indication to Stroke Prevention FDA Broadens Ticagrelor Indication to Stroke Prevention
In the THALES trial, ticagrelor plus aspirin led to a statistically significant reduction in stroke or death in with patients acute ischemic stroke or high-risk transient ischemic attack.FDA Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 6, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Alert Source Type: news

Researchers Say Aspirin May Help COVID Patients Researchers Say Aspirin May Help COVID Patients
Researchers have known since the early days of the coronavirus pandemic that infection increases the risk of sometimes deadly blood clots in the lungs, heart, and other organs.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 6, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Scientists investigate whether ASPIRIN could be used to treat deadly COVID-19 symptoms
COVID scientists are researching whether the commonly used medication aspirin could be used to treat the deadly symptoms of coronavirus. Experts leading the RECOVERY trial - including from the UK's University of Oxford - are hoping that aspirin could lower the risk of blood clots in patients. (Source: Daily Express - Health)
Source: Daily Express - Health - November 6, 2020 Category: Consumer Health News Source Type: news

Researchers Say Aspirin May Help COVID Patients
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 6, 2020 Category: General Medicine Source Type: news

Peter Sleight obituary
Cardiologist whose large-scale trials of emergency treatment for heart attack patients changed clinical practiceUntil the late 1980s, doctors had little to offer patients who had suffered from heart attacks. Half of them died within two hours. The remainder faced the risk of heart failure, further heart attacks and strokes, with similarly bleak outlooks. Combining scientific curiosity, intellectual rigour and clinical experience, Peter Sleight teamed up with statisticians and epidemiologists to conduct large-scale trials showing that speedy treatment with aspirin and other readily available drugs could significantly cut th...
Source: Guardian Unlimited Science - November 2, 2020 Category: Science Authors: Georgina Ferry Tags: Heart disease Medical research People in science US news Source Type: news

Aspirin Use May Up Outcomes in Hospitalized COVID-19 Patients
WEDNESDAY, Oct. 28, 2020 -- For hospitalized patients with COVID-19, aspirin use is associated with a reduced risk for mechanical ventilation, intensive care unit (ICU) admission, and in-hospital mortality, according to a study published online Oct.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 28, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus: Aspirin-taking patients '47% less likely to die'
A new study from the University of Maryland School of Medicine found that patients in the aspirin group were 43% less likely to be admitted to the ICU and 44% less likely to need ventilators. (Source: the Mail online | Health)
Source: the Mail online | Health - October 27, 2020 Category: Consumer Health News Source Type: news

Female sex as a risk factor for blunt cerebrovascular injuries and aspirin resistance - Paketci S.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - October 27, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Hospitalized patients taking aspirin daily were 47% less likely to die of COVID-19 
A new study from the University of Maryland School of Medicine found that patients in the aspirin group were 43% less likely to be admitted to the ICU and 44% less likely to need ventilators. (Source: the Mail online | Health)
Source: the Mail online | Health - October 27, 2020 Category: Consumer Health News Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revasculariz...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Can Aspirin Reduce Risk Of Death From Covid-19 Coronavirus? What This Study Really Said
The study showed associations between aspirin use and reduced risks of ICU admission, being placed on a ventilator, and death in those with severe Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 25, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Microbleeds Shouldn't Influence Anticoagulation After Stroke Microbleeds Shouldn't Influence Anticoagulation After Stroke
The increase in risk for intracerebral hemorrhage and ischemic stroke was similar with rivaroxaban and aspirin in a substudy of NAVIGATE-ESUS.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 23, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

New study: aspirin use reduces risk of death in hospitalized patients
(University of Maryland School of Medicine) Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 22, 2020 Category: Infectious Diseases Source Type: news

Anticoagulation therapy and fall reduction - O'Hanlon S.
To the Editor In their Teachable Moment, Edward and Gopal1 describe an important case in which unnecessary use of aspirin in addition to anticoagulation therapy likely caused a greater degree of injury than may have otherwise occurred to a man who had 2 me... (Source: SafetyLit)
Source: SafetyLit - October 21, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin
The high abundance of drug efflux pumps in cancer stem cells (CSCs) contributes to chemotherapy resistance. The transcriptional regulator SMAR1 suppresses CSC expansion in colorectal cancer, and increased abundance of SMAR1 is associated with better prognosis. Here, we found in breast tumors that the expression of SMAR1 was decreased in CSCs through the cooperative interaction of the pluripotency factors Oct4 and Sox2 with the histone deacetylase HDAC1. Overexpressing SMAR1 sensitized CSCs to chemotherapy through SMAR1-dependent recruitment of HDAC2 to the promoter of the gene encoding the drug efflux pump ABCG2. Treating ...
Source: Signal Transduction Knowledge Environment - October 20, 2020 Category: Science Authors: Bhattacharya, A., Mukherjee, S., Khan, P., Banerjee, S., Dutta, A., Banerjee, N., Sengupta, D., Basak, U., Chakraborty, S., Dutta, A., Chattopadhyay, S., Jana, K., Sarkar, D. K., Chatterjee, S., Das, T. Tags: STKE Research Articles Source Type: news

Use of Common Meds Tied to Lower Lung Cancer Mortality
Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 17, 2020 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

More Support for Shorter DAPT in High Bleeding Risk PCI More Support for Shorter DAPT in High Bleeding Risk PCI
In XIENCE stent-treated patients, aspirin monotherapy for 1 or 3 months was noninferior to historical controls for ischemic events, with significantly less major bleeding.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 16, 2020 Category: Cardiology Tags: Cardiology News Source Type: news